Abstract
In preclinical research, imaging instruments for single photon emission computed tomography (SPECT) allow to evaluate the biodistribution of gamma ray emitting radiopharmaceuticals inside the animal's body in vivo, in contrast with the ex vivo assessment of biodistribution, where the animal is euthanized to determine the radioactivity in individual organs in gamma counters. Additionally, …